Table 2 Characteristics of primary disease (pancreatic carcinoma)
FAS (N = 270) | SAF (N = 338) | ||
|---|---|---|---|
Time from diagnosis of primary tumor until informed consent [days] | n (number of patients) | 270 | 338 |
Mean (SD) | 168 (300) | 174 (332) | |
Median (Min, Max) | 36 (1, 2199) | 37 (1, 2383) | |
Time from occurrence of metastases until informed consent [days] | n (number of patients) | 265 | 333 |
Mean (SD) | 71 (119) | 78 (170) | |
Median (Min, Max) | 27 (1, 792) | 29 (1, 2383) | |
Localization of primary tumor [n (%)] a,b | Head of pancreas | 157 (58.1) | 190 (56.2) |
Tail of pancreas | 63 (23.3) | 73 (21.6) | |
Body of pancreas | 59 (21.9) | 72 (21.3) | |
Other | 10 (3.7) | 17 (5.0) | |
Localization of metastases [n (%)] b,c | Liver | 162 (60.7) | 199 (60.5) |
Lymph nodes | 71 (26.6) | 83 (25.2) | |
Peritoneum | 46 (17.2) | 56 (17.0) | |
Lung | 42 (15.7) | 51 (15.5) | |
Other | 53 (19.9) | 64 (19.5) | |
Tumor stage according to UICC [n (%)] a | IV (any T, any N, M1) | 219 (81.1) | 274 (81.1) |
III (T4, any N, M0) | 4 (1.5) | 5 (1.5) | |
IIb (T1-T3, N1, M0) | 12 (4.4) | 15 (4.4) | |
IIa (T3, N0, M0) | 2 (0.7) | 2 (0.6) | |
Ib (T2, N0, M0) | 1 (0.4) | 1 (0.3) | |
NA | 32 (11.9) | 41 (12.1) | |
Tumor histology [n (%)] a | Adenocarcinoma | 249 (92.2) | 306 (90.5) |
Papillary carcinoma | 0 | 1 (0.3) | |
Other | 8 (3.0) | 11 (3.3) | |
Not performed | 14 (5.2) | 21 (6.2) | |
Biliary stent [n (%)] a | No | 212 (78.5) | 266 (78.7) |
Yes | 58 (21.5) | 72 (21.3) | |